Analysts fell to the sidelines weighing in on Decibel Therapeutics (DBTX – Research Report), Galera Therapeutics (GRTX – Research Report) and Sonendo (SONX – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Decibel Therapeutics (DBTX)
Decibel Therapeutics received a Hold rating and a $5.25 price target from Robert W. Baird analyst Jack Allen today. The company’s shares closed last Wednesday at $5.03, close to its 52-week high of $5.68.
According to TipRanks.com, Allen has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Decibel Therapeutics has an analyst consensus of Hold, with a price target consensus of $6.13, a 29.1% upside from current levels. In a report released yesterday, H.C. Wainwright also downgraded the stock to Hold.
See today’s best-performing stocks on TipRanks >>
Galera Therapeutics (GRTX)
Piper Sandler analyst Edward Tenthoff downgraded Galera Therapeutics to Hold yesterday and set a price target of $0.50. The company’s shares closed last Wednesday at $2.24.
According to TipRanks.com, Tenthoff is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Galera Therapeutics with a $6.17 average price target.
Sonendo (SONX)
Piper Sandler analyst Jason Bednar downgraded Sonendo to Hold yesterday and set a price target of $1.00. The company’s shares closed last Wednesday at $1.25.
According to TipRanks.com, Bednar ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Currently, the analyst consensus on Sonendo is a Moderate Buy with an average price target of $2.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on DBTX:
